annual cash & cash equivalents:
$1.67B+$53.05M(+3.29%)Summary
- As of today (September 14, 2025), BIO annual cash & cash equivalents is $1.67 billion, with the most recent change of +$53.05 million (+3.29%) on December 31, 2024.
- During the last 3 years, BIO annual cash & cash equivalents has risen by +$790.41 million (+90.28%).
- BIO annual cash & cash equivalents is now -7.26% below its all-time high of $1.80 billion, reached on December 31, 2022.
Performance
BIO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.38B-$285.90M(-17.21%)Summary
- As of today (September 14, 2025), BIO quarterly cash & cash equivalents is $1.38 billion, with the most recent change of -$285.90 million (-17.21%) on June 30, 2025.
- Over the past year, BIO quarterly cash & cash equivalents has dropped by -$246.25 million (-15.18%).
- BIO quarterly cash & cash equivalents is now -33.83% below its all-time high of $2.08 billion, reached on March 31, 2022.
Performance
BIO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.3% | -15.2% |
| 3 y3 years | +90.3% | -30.3% |
| 5 y5 years | +48.7% | +32.2% |
BIO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.3% | +90.3% | -30.3% | at low |
| 5 y | 5-year | -7.3% | +90.3% | -33.8% | +57.1% |
| alltime | all time | -7.3% | >+9999.0% | -33.8% | >+9999.0% |
BIO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.38B(-17.2%) |
| Mar 2025 | - | $1.66B(-0.3%) |
| Dec 2024 | $1.67B(+3.3%) | $1.67B(+2.2%) |
| Sep 2024 | - | $1.63B(+0.5%) |
| Jun 2024 | - | $1.62B(-1.8%) |
| Mar 2024 | - | $1.65B(+2.4%) |
| Dec 2023 | $1.61B(-10.2%) | $1.61B(-8.6%) |
| Sep 2023 | - | $1.76B(+2.1%) |
| Jun 2023 | - | $1.73B(-6.9%) |
| Mar 2023 | - | $1.86B(+3.4%) |
| Dec 2022 | $1.80B(+105.2%) | $1.80B(-3.2%) |
| Sep 2022 | - | $1.86B(-6.0%) |
| Jun 2022 | - | $1.97B(-5.1%) |
| Mar 2022 | - | $2.08B(+137.5%) |
| Dec 2021 | $875.49M(-12.5%) | $875.49M(-35.0%) |
| Sep 2021 | - | $1.35B(+15.0%) |
| Jun 2021 | - | $1.17B(+13.8%) |
| Mar 2021 | - | $1.03B(+2.8%) |
| Dec 2020 | $1.00B(-10.7%) | $1.00B(-14.0%) |
| Sep 2020 | - | $1.16B(+11.8%) |
| Jun 2020 | - | $1.04B(-0.4%) |
| Mar 2020 | - | $1.05B(-6.7%) |
| Dec 2019 | $1.12B(+31.7%) | $1.12B(+13.7%) |
| Sep 2019 | - | $984.91M(-0.3%) |
| Jun 2019 | - | $987.53M(+14.2%) |
| Mar 2019 | - | $864.66M(+1.7%) |
| Dec 2018 | $850.47M(+11.7%) | $850.47M(-1.8%) |
| Sep 2018 | - | $866.23M(+5.1%) |
| Jun 2018 | - | $823.91M(+7.2%) |
| Mar 2018 | - | $768.58M(+0.9%) |
| Dec 2017 | $761.42M(-9.8%) | $761.42M(+5.6%) |
| Sep 2017 | - | $721.02M(+0.5%) |
| Jun 2017 | - | $717.41M(+5.7%) |
| Mar 2017 | - | $678.63M(-19.6%) |
| Dec 2016 | $844.00M(+6.8%) | $844.00M(+4.2%) |
| Sep 2016 | - | $810.33M(+1.8%) |
| Jun 2016 | - | $795.80M(+5.7%) |
| Mar 2016 | - | $752.87M(-4.8%) |
| Dec 2015 | $790.48M(+13.3%) | $790.48M(+0.6%) |
| Sep 2015 | - | $786.08M(+8.0%) |
| Jun 2015 | - | $727.65M(+2.4%) |
| Mar 2015 | - | $710.69M(+1.9%) |
| Dec 2014 | $697.63M(+14.6%) | $697.63M(-0.7%) |
| Sep 2014 | - | $702.58M(+8.5%) |
| Jun 2014 | - | $647.58M(+1.0%) |
| Mar 2014 | - | $641.33M(+5.3%) |
| Dec 2013 | $608.92M(-33.9%) | $608.92M(+8.4%) |
| Sep 2013 | - | $561.82M(-32.7%) |
| Jun 2013 | - | $834.43M(-0.3%) |
| Mar 2013 | - | $836.83M(-9.1%) |
| Dec 2012 | $921.07M(+13.3%) | $921.07M(+7.9%) |
| Sep 2012 | - | $853.62M(+2.2%) |
| Jun 2012 | - | $835.26M(+3.5%) |
| Mar 2012 | - | $807.05M(-0.7%) |
| Dec 2011 | $813.12M(-21.2%) | $813.12M(-10.7%) |
| Sep 2011 | - | $910.20M(+2.7%) |
| Jun 2011 | - | $886.25M(+11.1%) |
| Mar 2011 | - | $797.97M(-22.6%) |
| Dec 2010 | $1.03B(+38.5%) | $1.03B(+39.8%) |
| Sep 2010 | - | $738.00M(+2.8%) |
| Jun 2010 | - | $717.71M(+3.7%) |
| Mar 2010 | - | $691.78M(-7.1%) |
| Dec 2009 | $744.81M(+205.9%) | $744.81M(+16.0%) |
| Sep 2009 | - | $642.11M(+14.0%) |
| Jun 2009 | - | $563.36M(+152.8%) |
| Mar 2009 | - | $222.83M(-8.5%) |
| Dec 2008 | $243.47M(+8.8%) | $243.47M(+3.9%) |
| Sep 2008 | - | $234.31M(+3.2%) |
| Jun 2008 | - | $227.16M(+28.2%) |
| Mar 2008 | - | $177.12M(-20.8%) |
| Dec 2007 | $223.74M | $223.74M(-58.8%) |
| Sep 2007 | - | $543.40M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $502.87M(+6.6%) |
| Mar 2007 | - | $471.73M(-2.0%) |
| Sep 2006 | - | $481.57M(+11.0%) |
| Jun 2006 | - | $433.96M(+9.9%) |
| Mar 2006 | - | $394.76M(+0.1%) |
| Sep 2005 | - | $394.33M(+4.1%) |
| Jun 2005 | - | $378.95M(-1.3%) |
| Mar 2005 | - | $383.81M(+206.7%) |
| Sep 2004 | - | $125.15M(-19.4%) |
| Jun 2004 | - | $155.33M(+9.7%) |
| Mar 2004 | - | $141.55M(+0.6%) |
| Sep 2003 | - | $140.75M(+388.2%) |
| Jun 2003 | - | $28.83M(+14.3%) |
| Mar 2003 | - | $25.22M(-35.7%) |
| Sep 2002 | - | $39.25M(+53.0%) |
| Jun 2002 | - | $25.66M(-42.9%) |
| Mar 2002 | - | $44.95M(-4.6%) |
| Dec 2001 | - | $47.10M(+45.7%) |
| Sep 2001 | - | $32.33M(+223.5%) |
| Mar 2001 | - | $9.99M(-28.4%) |
| Dec 2000 | $13.95M(+28.7%) | $13.95M(+62.5%) |
| Sep 2000 | - | $8.59M(-34.3%) |
| Jun 2000 | - | $13.07M(-14.7%) |
| Mar 2000 | - | $15.32M(+32.1%) |
| Jun 1999 | - | $11.60M(+44.3%) |
| Mar 1999 | - | $8.04M(-3.6%) |
| Sep 1998 | - | $8.34M(-38.2%) |
| Jun 1998 | - | $13.48M(+6.8%) |
| Mar 1998 | - | $12.63M(+16.4%) |
| Dec 1997 | $10.84M(+15.5%) | $10.84M(+132.1%) |
| Sep 1997 | - | $4.67M(-14.8%) |
| Jun 1997 | - | $5.48M(-48.6%) |
| Mar 1997 | - | $10.67M(+13.6%) |
| Dec 1996 | $9.39M(-36.4%) | $9.39M(-62.9%) |
| Sep 1996 | - | $25.30M(-4.1%) |
| Jun 1996 | - | $26.40M(+46.7%) |
| Mar 1996 | - | $18.00M(+21.6%) |
| Dec 1995 | $14.77M(+293.9%) | $14.80M(+94.7%) |
| Sep 1995 | - | $7.60M(+52.0%) |
| Jun 1995 | - | $5.00M(-15.3%) |
| Mar 1995 | - | $5.90M(+55.3%) |
| Dec 1994 | $3.75M(+20.5%) | $3.80M(-2.6%) |
| Sep 1994 | - | $3.90M(-18.8%) |
| Jun 1994 | - | $4.80M(-15.8%) |
| Mar 1994 | - | $5.70M(+83.9%) |
| Dec 1993 | $3.11M(+15.9%) | $3.10M(+19.2%) |
| Sep 1993 | - | $2.60M(-33.3%) |
| Jun 1993 | - | $3.90M(+2.6%) |
| Mar 1993 | - | $3.80M(+40.7%) |
| Dec 1992 | $2.69M(-44.4%) | $2.70M(+12.5%) |
| Sep 1992 | - | $2.40M(-35.1%) |
| Jun 1992 | - | $3.70M(-27.5%) |
| Mar 1992 | - | $5.10M(+6.3%) |
| Dec 1991 | $4.83M(+66.1%) | $4.80M(+71.4%) |
| Sep 1991 | - | $2.80M(+12.0%) |
| Jun 1991 | - | $2.50M(-24.2%) |
| Mar 1991 | - | $3.30M(+65.0%) |
| Dec 1990 | - | $2.00M(-42.9%) |
| Sep 1990 | - | $3.50M(-28.6%) |
| Jun 1990 | - | $4.90M(0.0%) |
| Mar 1990 | - | $4.90M(+69.0%) |
| Dec 1989 | $2.91M(-26.4%) | $2.90M(-21.6%) |
| Sep 1989 | - | $3.70M(+60.9%) |
| Jun 1989 | - | $2.30M(-42.5%) |
| Dec 1988 | $3.95M(+104.8%) | $4.00M(+110.5%) |
| Dec 1987 | $1.93M(-7.0%) | $1.90M(-9.5%) |
| Dec 1986 | $2.08M(-65.5%) | $2.10M(-65.0%) |
| Dec 1985 | $6.01M(+584.2%) | $6.00M(+566.7%) |
| Dec 1984 | $878.00K(-45.7%) | $900.00K |
| Dec 1983 | $1.62M(+14.8%) | - |
| Dec 1982 | $1.41M(+69.2%) | - |
| Dec 1981 | $832.00K(-77.9%) | - |
| Dec 1980 | $3.77M | - |
FAQ
- What is Bio-Rad Laboratories, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. annual cash & cash equivalents year-on-year change?
- What is Bio-Rad Laboratories, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. quarterly cash & cash equivalents year-on-year change?
What is Bio-Rad Laboratories, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of BIO is $1.67B
What is the all time high annual cash & cash equivalents for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high annual cash & cash equivalents is $1.80B
What is Bio-Rad Laboratories, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, BIO annual cash & cash equivalents has changed by +$53.05M (+3.29%)
What is Bio-Rad Laboratories, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BIO is $1.38B
What is the all time high quarterly cash & cash equivalents for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high quarterly cash & cash equivalents is $2.08B
What is Bio-Rad Laboratories, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, BIO quarterly cash & cash equivalents has changed by -$246.25M (-15.18%)